The Valproate Mechanisms of Action in Migraine

Sorensen KV Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 1988;78:346–8

Hering R Kuritzky A Sodium valproate in the prophylactic treatment of migraine, a double-blind study versus placebo. Cephalalgia 1992;12:81–4

Mathew NT Sabiha A Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991;31:71–4

Hering R Steiner TJ Sodium valproate for the acute migraine attacks. Cephalalgia 1994;14:305–8

D'Andrea G Cananzi AR Joseph R Morra M Ferro-Milone F Zamberian F Fornasiero S Grunfeld S Welch KMA Platelet excitatory amino acids in migraine. Cephalalgia 1969;9:105–9

Ferrari MD Odink J Frolich M Tapparelli C Van Kempen GMJ Pennings EJM Bruyn GW Serotonin metabolism in migraine. Neurology 1969;39:1239–42

Ferrari MD Systemic biochemistry. In: Olesen J Tfelt-Hansen P Welch KMA , editors.The Headaches.New York:Raven Press,1993:179–63

Dooling EC Sweeney VP Migrainous hemiplegia during breast feeding. Am J Obstet Gynecol 1974;118:568–70

Kangasniemi P Sonninen U Rinne K Extraction of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervals. Headache 1972;3:62–5

Mitsikostas DD Sfikakis A Papadopouloy-Daifoti Z Varonos D The effects of valproate in brain monoamines of juvenile rats after stress. Prog Neuro-Psychopharmacol Biol Psychiatr 1993;17:295–310

Mitsikostas DD Papadopoulou-Daifoti Z Sfikakis A Valproate decreases dopamine concentrations in hypothalamus of prepubertal female rats (abstract). Epilepsia 1993;34 Suppl 2:162–3